These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1288507)

  • 61. Long-term therapy with slow-release nifedipine in essential hypertension.
    Arrigo F; Consolo F
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():941-5. PubMed ID: 2076404
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Controlled study with a new sustained-release formulation of nifedipine in essential hypertensive patients.
    Galletti F; Barba G; Nardecchia A; Strazzullo P; Scagliusi P; Pirrelli A; Mancini M
    J Clin Pharmacol; 1994 Sep; 34(9):919-23. PubMed ID: 7983235
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Haemodynamic effects of slow-release nifedipine in severe congestive heart failure due to ischaemic heart disease.
    Rossi A; Ziacchi V
    Cardiology; 1990; 77(6):450-8. PubMed ID: 2073662
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension.
    Frohlich ED; McLoughlin MJ; Losem CJ; Ketelhut R; Messerli FH
    Am J Cardiol; 1991 Nov; 68(13):1346-50. PubMed ID: 1951124
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nifedipine monotherapy in the hypertensive elderly: a placebo-controlled clinical trial.
    Schnapp P; Hermann H; Cernak P; Kahay J
    Curr Med Res Opin; 1987; 10(6):407-13. PubMed ID: 3552459
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antihypertensive, haemodynamic and metabolic effects of nifedipine slow-release tablets in elderly patients.
    Landmark K; Dale J
    Acta Med Scand; 1985; 218(4):389-96. PubMed ID: 3909759
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy.
    Brown MA; Buddle ML; Farrell T; Davis GK
    Am J Obstet Gynecol; 2002 Oct; 187(4):1046-50. PubMed ID: 12389003
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antihypertensive and metabolic effects of long-term therapy with nifedipine slow-release tablets.
    Landmark K
    J Cardiovasc Pharmacol; 1985; 7(1):12-7. PubMed ID: 2580130
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term antihypertensive and metabolic effects of nifedipine slow-release tablets in elderly hypertensives.
    Landmark K
    Acta Med Scand Suppl; 1986; 714():187-91. PubMed ID: 3472443
    [No Abstract]   [Full Text] [Related]  

  • 70. [Effect of Nifedipine (Adalat) on haemodynamic changes in patients with hypertension (author's transl)].
    Chvatíková J; Umnerová V; Ripka O
    Sb Lek; 1977 Mar; 79(3):78-81. PubMed ID: 850772
    [No Abstract]   [Full Text] [Related]  

  • 71. Chronopharmacokinetics and cardiovascular effects of nifedipine.
    Lemmer B; Nold G; Behne S; Kaiser R
    Chronobiol Int; 1991; 8(6):485-94. PubMed ID: 1799930
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prediction and optimisation of the antihypertensive response to nifedipine.
    Meredith PA; Donnelly R; Elliott HL
    Blood Press; 1994 Sep; 3(5):303-8. PubMed ID: 7866594
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Administration of nifedipine CR immediately after awakening prevents a morning surge in hypertensive patients. Case report of three cases.
    Kawano H; Ashizawa N; Toda G; Seto S; Yano K
    Blood Press Suppl; 2003 May; 1():44-8. PubMed ID: 12800987
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acute and long-term hypotensive effects and plasma concentrations of nifedipine in patients with essential hypertension.
    Aoki K; Sato K; Kawaguchi Y; Yamamoto M
    Eur J Clin Pharmacol; 1982; 23(3):197-201. PubMed ID: 7173292
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dose response and length of action of nifedipine capsules and tablets in patients with essential hypertension: a randomised crossover study.
    Cappuccio FP; Markandu ND; Tucker FA; MacGregor GA
    Eur J Clin Pharmacol; 1986; 30(6):723-5. PubMed ID: 3533567
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of two forms of sustained release nifedipine using 24 h ambulatory blood pressure monitoring.
    Gandhi AJ; Murphy CM; Zervopoulos PC; Evans RE; Carter BL; Bauman JL
    Am J Hypertens; 1997 Sep; 10(9 Pt 1):992-6. PubMed ID: 9324104
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetics and hemodynamic effects of long-term nifedipine treatment in hypertensive patients.
    Kleinbloesem CH; van Brummelen P; Faber H; Breimer DD
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):202-8. PubMed ID: 2435999
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapeutically relevant blood pressure differences with two nifedipine (60 mg) osmotic delivery systems of differing design: three case reports.
    Pollak PT
    Int J Clin Pharmacol Ther; 2010 Jun; 48(6):400-4. PubMed ID: 20497748
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical effect and safety of nifedipine controlled-release tablets combined with valsartan in the treatment of primary hypertension.
    Liu W; Liu Y; Fu J
    Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2419-2422. PubMed ID: 31894027
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine.
    Banzet O; Colin JN; Thibonnier M; Singlas E; Alexandre JM; Corvol P
    Eur J Clin Pharmacol; 1983; 24(2):145-50. PubMed ID: 6840159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.